Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects | Bone Marrow Transplantation
History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia | Atlantis Press
Frontiers | Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Oral Session | Bone Marrow Transplantation
PREDICTION OF LEUKEMIA FREE SURVIVAL FOLLOWING AUTOLOGOUS STEM CELL.... EHA Library. Shouval R. Jun 16 2018; 214557
Myeloid Malignancies | SpringerLink
Autologous stem cell transplantation versus alternative allogeneic donor transplants in adult acute leukemias - ScienceDirect
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for
Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects - Document - Gale OneFile: Health and Medicine
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allog
JCM | Free Full-Text | Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Current Oncology | Free Full-Text | Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
Cancers | Free Full-Text | Is There Still a Role for Autologous Stem Cell Transplantation for the Treatment of Acute Myeloid Leukemia?
Frontiers | Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant Relapse
Cancers | Free Full-Text | Autologous Transplantation for Older Adults with AML
Frontiers | Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | Haematologica
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT - Nagler -
PDF) Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT - Biology of Blood and
Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation - ScienceDirect
Minutes of Acute Leukemia Working Party (ALWP) Business Meeting
Frontiers | Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
